Press Release

October 12, 2018 Presentation at the AMED seminar, BioJapan 2018
Senior Director, Daisuke Morishita made an oral presentation at BioJapan 2018, titled “Novel tailor-made therapy for adult T-cell leukemia/lymphoma”, which is a collaborative research with Kyoto University, University of Miyazaki, National Cancer Center Japan and Chordia Therapeutics, Inc., at the Japan Agency for Medical Research and Development sponsor seminar, “The First Success Story (Drug Discovery) of Medical Research and Development Programs Focused on Technology Transfer: Acceleration Transformative Research for Medical Innovation (ACT-M)” held on October 12, 2018 at Pacifico Yokohama, Japan.